Curaleaf shares down 8% after FDA sends warning letter over CBD health claims
Cannabis Law Report
JULY 24, 2019
July 22, 2019. FDA has determined that your “CBD Lotion,” “CBD Pain-Relief Patch,” “CBD Tincture,” and “CBD Disposable Vape Pen” products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. RETURN RECEIPT REQUESTED. Joseph Lusardi, President.
51 
Let's personalize your content